FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367314181> ?p ?o ?g. }

• W4367314181 endingPage "11" @default.
• W4367314181 startingPage "1" @default.
• W4367314181 abstract "To identify central-line (CL)-associated bloodstream infection (CLABSI) incidence and risk factors in low- and middle-income countries (LMICs).From July 1, 1998, to February 12, 2022, we conducted a multinational multicenter prospective cohort study using online standardized surveillance system and unified forms.The study included 728 ICUs of 286 hospitals in 147 cities in 41 African, Asian, Eastern European, Latin American, and Middle Eastern countries.In total, 278,241 patients followed during 1,815,043 patient days acquired 3,537 CLABSIs.For the CLABSI rate, we used CL days as the denominator and the number of CLABSIs as the numerator. Using multiple logistic regression, outcomes are shown as adjusted odds ratios (aORs).The pooled CLABSI rate was 4.82 CLABSIs per 1,000 CL days, which is significantly higher than that reported by the Centers for Disease Control and Prevention National Healthcare Safety Network (CDC NHSN). We analyzed 11 variables, and the following variables were independently and significantly associated with CLABSI: length of stay (LOS), risk increasing 3% daily (aOR, 1.03; 95% CI, 1.03-1.04; P < .0001), number of CL days, risk increasing 4% per CL day (aOR, 1.04; 95% CI, 1.03-1.04; P < .0001), surgical hospitalization (aOR, 1.12; 95% CI, 1.03-1.21; P < .0001), tracheostomy use (aOR, 1.52; 95% CI, 1.23-1.88; P < .0001), hospitalization at a publicly owned facility (aOR, 3.04; 95% CI, 2.31-4.01; P <.0001) or at a teaching hospital (aOR, 2.91; 95% CI, 2.22-3.83; P < .0001), hospitalization in a middle-income country (aOR, 2.41; 95% CI, 2.09-2.77; P < .0001). The ICU type with highest risk was adult oncology (aOR, 4.35; 95% CI, 3.11-6.09; P < .0001), followed by pediatric oncology (aOR, 2.51;95% CI, 1.57-3.99; P < .0001), and pediatric (aOR, 2.34; 95% CI, 1.81-3.01; P < .0001). The CL type with the highest risk was internal-jugular (aOR, 3.01; 95% CI, 2.71-3.33; P < .0001), followed by femoral (aOR, 2.29; 95% CI, 1.96-2.68; P < .0001). Peripherally inserted central catheter (PICC) was the CL with the lowest CLABSI risk (aOR, 1.48; 95% CI, 1.02-2.18; P = .04).The following CLABSI risk factors are unlikely to change: country income level, facility ownership, hospitalization type, and ICU type. These findings suggest a focus on reducing LOS, CL days, and tracheostomy; using PICC instead of internal-jugular or femoral CL; and implementing evidence-based CLABSI prevention recommendations." @default.
• W4367314181 created "2023-04-29" @default.
• W4367314181 creator A5000297555 @default.
• W4367314181 creator A5006366945 @default.
• W4367314181 creator A5007273265 @default.
• W4367314181 creator A5008156811 @default.
• W4367314181 creator A5008176133 @default.
• W4367314181 creator A5008680164 @default.
• W4367314181 creator A5009239411 @default.
• W4367314181 creator A5009569793 @default.
• W4367314181 creator A5015599303 @default.
• W4367314181 creator A5017368544 @default.
• W4367314181 creator A5019422249 @default.
• W4367314181 creator A5020254299 @default.
• W4367314181 creator A5021198421 @default.
• W4367314181 creator A5022399132 @default.
• W4367314181 creator A5023218842 @default.
• W4367314181 creator A5023633356 @default.
• W4367314181 creator A5025710162 @default.
• W4367314181 creator A5029179912 @default.
• W4367314181 creator A5029334251 @default.
• W4367314181 creator A5031781924 @default.
• W4367314181 creator A5034141994 @default.
• W4367314181 creator A5034855451 @default.
• W4367314181 creator A5038722825 @default.
• W4367314181 creator A5043263331 @default.
• W4367314181 creator A5043291091 @default.
• W4367314181 creator A5044194314 @default.
• W4367314181 creator A5044529313 @default.
• W4367314181 creator A5046190497 @default.
• W4367314181 creator A5048767854 @default.
• W4367314181 creator A5050773667 @default.
• W4367314181 creator A5053780909 @default.
• W4367314181 creator A5054112040 @default.
• W4367314181 creator A5054519393 @default.
• W4367314181 creator A5057476963 @default.
• W4367314181 creator A5057878360 @default.
• W4367314181 creator A5063580131 @default.
• W4367314181 creator A5064739238 @default.
• W4367314181 creator A5065280138 @default.
• W4367314181 creator A5066227238 @default.
• W4367314181 creator A5066454415 @default.
• W4367314181 creator A5068178034 @default.
• W4367314181 creator A5068371354 @default.
• W4367314181 creator A5069988148 @default.
• W4367314181 creator A5074027753 @default.
• W4367314181 creator A5074746182 @default.
• W4367314181 creator A5077222085 @default.
• W4367314181 creator A5077817231 @default.
• W4367314181 creator A5080204995 @default.
• W4367314181 creator A5080500886 @default.
• W4367314181 creator A5083338687 @default.
• W4367314181 creator A5083646197 @default.
• W4367314181 creator A5083805418 @default.
• W4367314181 creator A5086041840 @default.
• W4367314181 creator A5090394944 @default.
• W4367314181 creator A5091071550 @default.
• W4367314181 date "2023-04-28" @default.
• W4367314181 modified "2023-10-02" @default.
• W4367314181 title "Multinational prospective study of incidence and risk factors for central-line–associated bloodstream infections in 728 intensive care units of 41 Asian, African, Eastern European, Latin American, and Middle Eastern countries over 24 years" @default.
• W4367314181 cites W1807941019 @default.
• W4367314181 cites W1975192439 @default.
• W4367314181 cites W1976430195 @default.
• W4367314181 cites W1977844873 @default.
• W4367314181 cites W1978159568 @default.
• W4367314181 cites W2016632927 @default.
• W4367314181 cites W2018480680 @default.
• W4367314181 cites W2031157763 @default.
• W4367314181 cites W2040402741 @default.
• W4367314181 cites W2061949853 @default.
• W4367314181 cites W2074605595 @default.
• W4367314181 cites W2085379676 @default.
• W4367314181 cites W2104012485 @default.
• W4367314181 cites W2109141501 @default.
• W4367314181 cites W2113942797 @default.
• W4367314181 cites W2124419853 @default.
• W4367314181 cites W2128241338 @default.
• W4367314181 cites W2128317176 @default.
• W4367314181 cites W2142187509 @default.
• W4367314181 cites W2144391512 @default.
• W4367314181 cites W2150075911 @default.
• W4367314181 cites W2156036886 @default.
• W4367314181 cites W2161959762 @default.
• W4367314181 cites W2162373825 @default.
• W4367314181 cites W2165306805 @default.
• W4367314181 cites W2294187522 @default.
• W4367314181 cites W2442818497 @default.
• W4367314181 cites W2518170607 @default.
• W4367314181 cites W2883264965 @default.
• W4367314181 cites W3157655453 @default.
• W4367314181 cites W4214656580 @default.
• W4367314181 cites W4226062533 @default.
• W4367314181 cites W4294989858 @default.
• W4367314181 cites W4296023632 @default.
• W4367314181 cites W4307181518 @default.
• W4367314181 doi "https://doi.org/10.1017/ice.2023.69" @default.
• W4367314181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37114756" @default.
• W4367314181 hasPublicationYear "2023" @default.

• next